Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page
US FDA clears Apple Watch hypertension feature

US FDA clears Apple Watch hypertension feature

by AIP Online Bureau | Sep 13, 2025 | Data, Eco/Invest/Demography, Health, Risk Management, Technology

The company unveiled a blood pressure monitor in its latest Apple Watch at a September 9 event, where it also introduced a refreshed iPhone lineup, including a slimmer iPhone Air. Apple said the new hypertension notification feature will be available on Apple Watch...

US FDA seeks fresh curbs on sodium levels in packaged, processed foods

by AIP Online Bureau | Aug 15, 2024 | Health, International News

“Reducing sodium in the food supply has the potential to be one of the most important public health initiatives in a generation,” FDA Deputy Commissioner for Human Foods Jim Jones said in a statement Fast-food chains, including McDonald’s , Burger...

Generic-Viagra safety called into doubt after FDA finds false data by an Indian company

by AIP Online Bureau | Jul 11, 2024 | Health, International News, Risk Management

Data from the researcher, Synapse Labs Pvt. Ltd., may have been used in hundreds of drugs, which remain available for sale on pharmacy shelves and in Americans’ medicine cabinets Generic versions of erectile dysfunction drugs Viagra and Cialis, among other...

US food regulator gathering information on Indian spices after alleged contamination

by AIP Online Bureau | Apr 27, 2024 | Indian News, Regulation, Risk Management

MDH and Everest spices are among the most popular in India and are also sold in Europe, Asia and North America. India’s food regulator, the Food Safety and Standards Authority of India (FSSAI), is now checking the quality standards of the two companies,...

U.S. FDA says India-made eye drop linked to some infections, blindness and one death

by AIP Online Bureau | Feb 4, 2023 | Health, International News, Regulation

The agency said on Thursday that Artificial Tears eye drop manufactured by India’s Global Pharma Healthcare Pvt Ltd has a potential bacterial contamination and the company has violated current good manufacturing practices The U.S. Food and Drug Administration...
« Older Entries

Recent Posts

  • India’s Cloudburst Challenges:Insurance gaps & Future safeguards
  • Aerospace Industry: Facing strong supply chain headwinds
  • Tesla’s European regulator says door safety a ‘Key Priority’
  • UK sanctions Russia’s Lukoil and Rosneft, targets shadow fleet
  • Jio Insurance Broking earns Rs 347 cr in premiums, issues 2.9 lakh policies in Q2FY26

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy